// App-Quantinova.ai

3768 : Targeting of epithelial-to-mesenchyme transition by a novel small molecule inhibitor attenuates prostate and breast cancer invasiveness and bone metastases

Researchers

Presenter

  • Jan Kroon

Principal Investigators

  • Onno van Hooij

  • Eugenio Zoni

  • Maaike van der Mark

  • Geertje van der Horst

  • Johan Tijhuis

  • Cindy van Rijt-van de Westerlo

  • Gerald Verhaegh

  • Henk Vietor

  • Antoine Wellink

  • Peter Maas

  • Jack Schalken

  • Gabri van der Pluijm

Medical Centers

  • Leiden University Medical Centre, Leiden, Netherlands

  • Radboud University Medical Center, Njmegen, Netherlands

  • SPECS, Zoetermeer, Netherlands

  • Oncodrone B.V., Nijmegen, Netherlands.

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bone metastases

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Cadherin 1

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved